Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Dementia Conference 2019

About Conference

It’s our pleasure to welcome you to the Dementia Conferences 2019 in the long stretch of November 14-15, 2019 Abu-Dhabi, UAE. The gathering will be deal with around the subject of "Promising Growth Towards Pinnacle in Dementia Science"

ME Conferences usually respects participants all over the globe to join "14th Annual Conference on Dementia and Alzheimer's Disease" scheduled on November 14-15, 2019 at Abu-Dhabi, UAE. It associates with prompt keynote sessions, Oral talks, Poster presentations,  Exhibitions and many more…..

Dementia, together with Alzheimer's affliction, is one of the best overall prosperity challenges facing our old generation.. Everywhere in the globe 44 million people are living with dementia,  this is doubled to 2030  and more than triple by 2050 to 115 million. 

Can we cure Dementia?

Discovering the friend or family member has Alzheimer's or other types of dementia is Scary. One of the primary inquiry is individuals inquires as to whether there is a cure or an approach to recouping? Not all loss of memory is recognized with Alzheimer's or dementia. There are different reasons you may encounter memory issues including thyroid issues, stretch and vitamin insufficiencies or certain medicines.

There is currently no "cure" for dementia. Dementia is triggered by different diseases, that’s why  it is impossible that there will be a solitary cure for dementia

Our conference raises the following questions at Abu-Dhabi:

  • What do you think about  Alzheimer's disease - the biggest public misconceptions
  • Will science ever discover a treatment for Alzheimer's?
  • What are the recent scientific advances in treating or understanding Alzheimer's would you say you are most amped up for?
  • How will these change will diagnosis of the disease?

Sessions / Tracks

Track: Alzheimer’s Diseases

Alzheimer's disease is irreversible and decimates cerebrum cells, making thinking capacity and memory weaken. Alzheimer's infection is a degenerative, dynamic mind ailment and the most broadly recognized type of dementia and gathering of brain disorders that influence a man's memory, considering and capacity to connect socially. Dementia and Alzheimer's infection isn’t the same. Dementia is a general term used to depict indications that effect memory, execution of day by day exercises, and correspondence capacities. Alzheimer's infection is that the most generally recognized reasonably insanity. Exercise programs may be beneficial with respect to activities of daily living and can potentially improve outcomes. Alzheimer’s illness isn't a typical piece of maturing. We are leading exploration into the part of aggravation in Alzheimer's sickness to discover potential focuses for remedial mediation. The Dominantly Inherited Alzheimer Network is the main aim to discover biomarkers for Alzheimer's Diseases that are perceptible some time before the underlying clinical side effects. Member’s expertise neural structure checks and clinical evaluations and provides blood and spinal liquid to explore. Presently utilizing hereditary linkage ways in which to subsume endeavour to tell apart these modifier qualities, which can provide useful focuses to the treatment of Alzheimer's disease illness.

Track: Parkinson’s Diseases

Parkinson's ailment (PD) is an un ending and dynamic neurological disorders that influence the engine work, causing bradykinesia, postural unsteadiness, inflexibility and tremor very still. Side effects grow progressively, making start finding troublesome. PD likewise has a few non-engine highlights, including psychological wellness issues, rest unsettling influences and autonomic aggravations. At introduce, there is no cure for PD. The treatment is, subsequently, gone from treating side effects. There are right now two fundamental ways to deal with enhanced dopaminergic action inside the mind: expanding dopamine emission with exogenous operators and focusing on related neurotransmission pathways. Levodopa is the regular metabolic antecedent of dopamine and is profoundly successful for treating PD indications. Side effects of Parkinson's Diseases are normally overseen utilizing a specific dopamine receptor agonist. While these medications are valuable in beginning time Parkinson's, they tend to lose viability in later sickness stages.

Track: Vascular Dementia

Vascular Dementia is that the second most regular reason for insanity once Alzheimer's Diseases. Vascular changes that begin in mind territories that assume a key half in putt away and sick information could cause memory misfortune that appears particularly like Alzheimer's disease sickness. Vascular dementedness may be a decrease in intuition skills caused by conditions that sq.or diminish blood stream to the brain, denying mind cells of fundamental oxygen and supplements. Deficient blood stream can harm and, in the end, dead cells anyplace in the body. The mind has one in all the body's richest systems of veins and is especially helpless. In tube insanity, changes in speculation talents currently so happen suddenly following strokes that sq. important neural structure veins. A developing variety of specialists lean toward the expression "Vascular cognitive Impairment (VCI)" to "vascular dementia”. A few examinations have discovered that vascular changes and different neural structure irregularities could associate in ways in which improve the chance of dementedness finding. The analysis of dementia or mild psychological electric resistance is affirmed by neurocognitive testing, which has some hours of composed or mechanized tests that offer purpose by purpose assessment of reasoning skills, for instance, judgment, arranging, crucial thinking, thinking and memory.

Track: Childhood Trauma and Dementia

New analysis recommends there's a solid relationship between initial childhood trauma as an example, that accomplished by the purloined ages and dementedness. There is associate expansive agreement demonstrating that childhood trauma is basically related to the advance of sorrow. There is a solid connection between a high introduction to early life stress and affliction that incorporates individuals that were a piece of the stolen ages, and the probability of being determined to possess dementedness someday down the road. Psychic trauma or any psychological disorders that unexpectedly overpowers the ability to give a negligible feeling of wellbeing and integrative wholeness, bringing about overpowering nervousness or defencelessness, or its danger, and making a seamless modification within the psychic organization. Childhood trauma will influence mental and physical welfare into adulthood.

Track: Alzheimer Disease and Cellular Mechanisms

Most continuous endeavours to battle Alzheimer Disease (AD) are centered around treating its clinical symptoms, however the neuropathologic changes fundamental AD show up decades sooner and turn out to be basically irreversible when the sickness achieves its clinical stages. This requires treating AD at preclinical stages, which requires a superior  comprehension of the essential instruments prompting Alzheimer Disease pathology. Alzheimer's infection (AD) is a complex hereditary issue that is the main source of dementia in the elderly. Atomic confirmation raised the presumptions that trafficking of the amyloid precursor protein (APP) is under control of insulin flagging. Most progressing endeavours to battle Alzheimer Disease (AD) are centered around treating its clinical side effects, however the neuropathologic changes fundamental AD show up decades sooner and turn out to be basically irreversible when the ailment achieves its clinical stages.

Track: Neurovascular Dysfunction and Neurodegeneration

Vascular insults will begin a course of Molecular event occasions prompting neurodegeneration, psychological disorders and dementia. Here, the molecular mechanisms and cell in cerebral veins pathophysiological occasions prompting disturbance of the blood-cerebrum obstruction and cerebral blood stream dysregulation and conjointly the neurovascular unit, which all may add to the start and movement of insanity and Alzheimer's disease. From the foremost on time phases of improvement, once cerebral development and development area unit weaved, to the end of life, the interaction between neural frameworks and tube of the neural structure is basic in wellbeing and infection. Cerebral blood stream management is key for standard mind work. The class mind has developed associate exceptional system for CBF management referred to as neurovascular coupling.

Track: Molecular Genetics and Biology of Dementia

Molecular biology analysis has significantly concentrated our understanding of the pathophysiological basis of Alzheimer's disease dementia. Considerable progress has been created in our understanding of the genetic science and biological science of dementedness. Some genetic risk factors are known to this point, however solely a tiny low proportion of AD cases will be explained by specific sequence mutations. Genes could also be associated with sickness in 2 ways: through autosomal-dominant mutations, in themselves decent to cause the sickness as an alternative, factor variations (polymorphisms) could indirectly increase sickness risk while not being sufficient in themselves to cause the disorder.

Track: Medical Biotechnology and Alzheimer’s Disease

Alzheimer's disease as a dynamic associate decreed fatal neurodegenerative disease speaks to an vast neglected demand for treatment. One of the elemental boundaries is that the blood brain boundary. The expanding predominance of Alzheimer's Diseases and the low viability of ebb and flow treatments have expanded the measure of research on unwinding of sickness pathways and advancement of treatment techniques. One of the alluring regions for the last subject is biotechnology and their applications. Nanotechnology is a standout amongst the most vital field in biotechnology and has a noteworthy part in the improvement of novel remedial modalities with expanded adequacy. In the engineering field, materials are designed with utilitarian association on the nano scale. One of the first problems regarding the treatment of neurodegenerative diseases are known with medicates conveyance.

Track: Neuroimaging Biomarker

Alzheimer's Disease biomarkers with emphasis on cerebrospinal fluid biomarkers and neuroimaging. Mild psychological feature Impairment (MCI) of Neuroimaging biomarkers permits an early designation in presymptomatic stages of Alzheimer’s sickness. Biomarker changes in patients with late-onset AD, together with findings from studies mistreatment structural and practical resonance  imaging (MRI), advanced tomography techniques (diffusion tensor imaging, resonance qualitative analysis, perfusion)positron emission pictorial representation with fluorodeoxyglucose, amyloid tracers, and other neurochemical tracers and CSF protein levels.

Track: Neurological Diseases

Neurological disorders are the maladies of the focal and fringe sensory system. At the tip of the day, spinal rope, os nerves, fringe nerves, nerve roots, involuntary sensory system and contractile organ intersection. These disarranges incorporate brain disease, Alzheimer health problem and totally different dementias, vessel sicknesses together with stroke, headache and alternative headache issue, numerous induration, Parkinson infection, neuroinfectious, mind tumors, awful scatters of the sensory system. Neurological manifestations could happen owing to the contamination itself or owing to a secure reaction. Countless individuals worldwide are influenced by neurological disarranges. Alzheimer's sickness is the most widely recognized reason for dementia and may add to 60– 70% of cases.

Track: Neurodegenerative Diseases

Neurodegenerative sicknesses are crippling, and it is a heterogeneous gathering of disarranges of serious conditions that outcome in dynamic degeneration. Neurodegenerative maladies cause issues with development called ataxias, or mental working called dementias. Neurodegenerative infections happen when nerve cells in the mind or fringe sensory system lose work after some time and at last pass on. Although medicines may help diminish a portion of the physical or mental side effects related with neurodegenerative infections, there is right now no cure or approach to moderate ailment movement. The danger of being influenced by a neurodegenerative increment drastically with age. A great little extent under five level of neurodegenerative infections are caused by hereditary changes. This makes a basic need to enhance our comprehension of what causes the neurodegenerative infections and grow new methodologies for treatment and counteractive action.

Track: Alzheimer’s and the Brain

The brain usually a therapist to a point in solid maturing in any case, shockingly, doesn’t lose neurons in immense numbers. In Alzheimer's illness, be that because it could, hurt is across the board, constant variety of neurons quit operating, lose associations with totally different neurons, and pass away. Alzheimer's disturbs forms basic to neurons and their systems, together with correspondence, digestion, and repair. Acetylcholine is a neurotransmitter that is insufficient in individuals with Alzheimer's, the place beginning memory misfortune is trailed by more far reaching changes in considering and conducts that prompt lost freedom. Numerous molecular and cell changes happen in the mind of a man with Alzheimer's illness.

Track: Alzheimer’s Clinical Trials and Studies

To evaluate the protection Associate in Nursing effectuality of an oral investigational drug in people World Health Organization square measure well and at-risk for Alzheimer's and work the impact of brainpan infusion on Alzheimers disease progression in people with prodromal or delicate un wellness Alzheimer's disease. Presently the clinical trials and studies square measure chiefly concentrating on Alzheimer’s sickness , aging to possess the most effective probability of adjusting the outlook for individuals with insanity promising ideas should be driven through the event method and into clinical trials in individuals as quickly as doable.

Track: Diagnostic Alzheimer

Doctors cannot analyse Alzheimer’s disease till once death, once they will nearly examine the brain beneath a magnifying instrument. However, they'll utilize tests to make a decision out completely different conditions that will cause similar symptoms. Early finding is advantageous for a few reasons. Starting treatment ahead of schedule in the illness procedure may help protect day by day working for quite a while, even though the hidden Alzheimer's procedure can't be ceased or switched. Alzheimer's dementia comes about because of the dynamic misfortune (degeneration) of brain cells. This Movement could seem in associate degree assortment of courses in brain scans. At present researchers area unit exploring a couple of upset markers and demonstrative tests, for example, qualities, infection related proteins and imaging methods, which may precisely and dependably show whether you have Alzheimer's dementia or not. Whatever, without delay additional analysis on these tests is vital for future.

Track: Dementia Care and Consulting

Caring for an individual with dementia influences distinctive people in numerous ways in which. In any case, caring also can be each physically and rationally debilitating. It influences all aspects of your life and may influence you to feel separated, pushed and now and then even discouraged. You may even have your own physical and psychological eudaemonia wants, which you and others may neglect when you are tending to another person. There are numerous positive things about caring. These incorporate adapting new aptitudes, increasing on existing ones, reinforcing connections, having a sense of pride in what you're doing, and supporting someone WHO is imperative to you. Furthermore, as a result of a person has dementedness, it doesn't suggest there will not in any case be nice circumstances for you to share.

Market Analysis

The global market for Alzheimer’s disease therapeutics and diagnostics may reach over $6.2 billion by 2020 from $4.4 billion in 2015 by region, at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020.

Report Includes:

  • An overall view of the worldwide market for Alzheimer's disease therapeutic and diagnostic technologies
  • Analysis of global market trends, with data from 2014, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2020.

Anti-Parkinson's Drugs: Global Market Analysis

The worldwide anti-Parkinson’s drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1%, from 2017 to 2022.

  • Asia Pacific anti-Parkinson’s drugs market is expected to grow from $1.0 billion in 2017 to $1.4 billion in 2022 at a CAGR of 6.4% for the period 2017-2022.
  • North American anti-Parkinson’s drugs market is expected to grow from $1.3 billion in 2017 to $1.8 billion in 2022 at a CAGR of 7.0% for the period 2017-2022
  • Europe anti-Parkinson’s drugs market is estimated to grow from $1.5 billion in 2017 to $1.9 billion in 2022 at a CAGR of 9.0% for the period 2017-2022

Global Anti-Parkinson’s Drugs Forecast Market, Through 2022:

Reasons for Doing This Study:

The global anti-Parkinson’s drugs market is growing due to a rise in the aging population, growing awareness, increasing health insurance reforms and constant research and development in anti-Parkinson’s drugs by pharmaceutical companies. These factors along with technological advances such as biomarkers, 3D printed drugs, mobile applications and wearable technologies used to monitor and treat patients diagnosed with Parkinson’s disease are expected to drive the anti-Parkinson’s drugs industry

Major Alzheimer’s Disease Journals Globally:

  • The Journal of the Alzheimer’s Association
  • International Journal of Alzheimer's Disease
  • Journal of Alzheimer’s Disease
  • Journal of Community Health Research
  • Asia Pacific Family Medicine
  • Journal of School of Public Health and Institute of Public Health Research
  • AIMS Public Health
  • An International Journal on Alzheimer’s Disease and Associated Disorders
  • African Journal of Primary Health Care & Family Medicine
  • Indian Journal of Community Medicine
  • The Global Voice on Dementia
  • International Journal of Family Medicine
  • National Journal of Community Medicine

Related Societies:


American Academy of NeurologyAmerican Spinal Injury AssociationAmerican Epilepsy SocietyAmerican Association of Neurological SurgeonsChild Neurology SocietyThe American Clinical Neurophysiology SocietyAmerican Psychological Association‎American surgical organizations‎; Medical and health professional associations in Chicago‎ ; American Academy of Family Physicians‎; American Association for Cancer Research; American dental organizations‎; American Psychiatric Association‎

European Societies:

European Neurological SocietyWorld Federation of NeurologyInternational Brain Research OrganizationWorld Stroke Organization;  Movement Disorders SocietyAmerican Academy of NeurologyAlbanian Society of NeurologyArmenian Scientific-Practical Union of NeurologistsAustrian Society of NeurologyBelarusian Scientific Society of NeurologistsBulgarian Society of NeurologyCroatian Neurological SocietyCyprus Neurological SocietyCzech Neurological SocietyDanish Neurological Society ; Estonian Ludwig puusepp Society of Neurologists & NeurosurgeonsMacedonian Society of NeurologyFinnish Neurological Association ; French Society of Neurology ; Georgian Society of NeurologistsGerman Society of Neurology Hellenic Neurological SocietyIcelandic Neurological SocietyIrish Institute of Clinical NeuroscienceItalian Society of NeurologyLithuanian Neurological AssociationLuxembourg Society of Neurology ; Moldovan Scientific Society of NeurologistsMontenegrin Neurological Association; Norwegian Neurological AssociationPolish Neurological SocietyRomanian Society of NeurologyAll-Russian Society of NeurologistsNeurological Society of SerbiaSlovak Neurological SocietySlovenian Society of NeurologySpanish Society of NeurologySwedish Neurological SocietySwiss Society of Neurology ; Netherlands Society of Neurology ; Turkish Neurological SocietyScientific Society of Neurologists of the UkraineAssociation of British NeurologistsNational Neurological Society of Uzbekistan

Asia & Middle East:

Turkish neurological SocietySouth Africa Neurological SocietyIndonesia Pediatric Society; Romania Society of NeurologyAfghan Neurological AssociationBahrain Neurosciences AssociationChinese Neurological Society; Hong Kong Neurological SocietyIndian Academy of NeurologyIndonesian Neurological AssociationIranian Neurological AssociationIraq Neurological SocietyIsrael Neurological AssociationJapanese Society of NeurologyThe Jordan Neurological SocietyLeague of Neurologists of KazakhstanKorean Neurological AssociationKuwait Neurological SocietyNational Association of Neurologists of the Kyrgyz Republic ; Malaysia Society of NeuroscienceMongolian Association of NeurologistMyanmar Society of NeurologyOman Neurology SocietyPakistan Society of NeurologyPalestinian Neurological SocietyPhilippian Neurological SocietyQatar Neuroscience ClubSaudi Neurological SocietyClinical Neuroscience society SingaporeAssociation of Sri Lankan NeurologistSyrian Society of NeuroscienceTaiwan Neurological SocietyThe Neurological Society Of ThailandEmirates Neuroscience SocietyNational Neurological Society of Uzbekistan; Vietnamese Association of NeurologyYemeni Neuroscience Society

Related Conferences:

Past Conference Report

Dementia 2018

Gratitude’s to all of our honorable speakers, conference attendees, and sponsors. DEMENTIA 2018

The conference was our best ever!

13th Annual Conference on Dementia and Alzheimer’s Disease, hosted by the ME Conferences Group were held during December 13-15, 2018 Abu Dhabi, UAE at Bab Al Qasr Hotel, Abu Dhabi, UAE with the theme “Making A Move on Dementia: New Answers to Old Questions”. Magnanimous response and active participation were received from the Editorial Board Members of Alzheimer’s Disease & Parkinsonism as well as from the Scientists, Doctors, Professors, Neurologists, Radiologists, Pharmaceutical Industries, Healthcare Industries, Researchers and Students from the field of Neurology, who made this event successful.

ME Conferences Group played host to a diverse panel of key members of the DEMENTIA 2018 community from research lab, industry, academia, and financial investment practices, discussing the future of Neurology, Alzheimer’s Diseases, Parkinson’s Diseases, Alzheimer Disease and Cellular Mechanisms, Molecular Genetics and Biology of Dementia, Dementia Care and Consulting. This event was really aimed for examining where the technology is going in the future and purpose of the event was to provide an opportunity for cross-fertilization and development of ideas, in this field.

Focusing on Alzheimer’s Diseases, Parkinson’s Diseases, Vascular Dementia, Childhood Trauma and Dementia, Alzheimer Disease and Cellular Mechanisms, Neurovascular Dysfunction and Neurodegeneration, Molecular Genetics and Biology of Dementia, Medical Biotechnology and Alzheimer’s disease, Neuroimaging Biomarker, Neurological Diseases, Neurodegenerative Diseases, Alzheimer’s and the Brain the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

DEMENTIA 2018 Organizing Committee would like to thank the Organizing Committee Member of the conference Ghulam Md Ashraf, King Abdulaziz University, Saudi Arabia who contributed a lot for the smooth functioning of this event.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by a series of lectures delivered by Honourable Guests and members of the Keynote forum.

The highlights of the meeting were the eponymous lectures, delivered by:

  • Abha Chauhan, NYS Institute for Basic Research in Developmental Disabilities, USA

  • Ganiyu Oboh, Federal University of Technology, Nigeria

  • Ved Chauhan, NYS Institute for Basic Research in Developmental Disabilities, USA

  • Sundas Hira, Riphah International University, Pakistan

  • Opeyemi Babatunde Ogunsuyi, Federal University of Technology, Nigeria

  • Malka Ceh, Sigmund Freud University, Austria

  • Satyaprakash Tiwari, Jamiyah Nursing Home, Singapore

  • Ghulam Md Ashraf, King Abdulaziz University, Saudi Arabia

  • Zahra Vahabi, Tehran University of Medical Sciences, Iran

  • Muhammad Asif Rasheed, COMSATS University Islamabad, Pakistan

  • Ahmed Saadeldin Hussein Hamed, Ain Shams University School of Medicine, Egypt

These talks were of great interest to the general Dementia and Alzheimer’s and were enormously informative.

13th Annual Conference on Dementia and Alzheimer’s disease was a great success with the support of the Journal of Dementia, Alzheimers Disease & Parkinsonism, and Journal of Neurological Disorders. We are happy to announce our 14th Annual Conference on Dementia and Alzheimer’s disease to be held during November 14-15, 2019 Abu-Dhabi in UAE.

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 14-15, 2019

Speaker Opportunity

Supported By

Journal of Dementia Journal of Alzheimers Disease & Parkinsonism Journal of Neurological Disorders

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner




Media Partner


Media Partner


Media Partner




Media Partner




Media Partner


Media Partner


Media Partner


  • Alzheimers
  • Alzheimers Disease
  • Alzheimers Disease And Dementia
  • Amyloid And Tau Imaging
  • Amyloid Protein In Dementia
  • Animal Models And Translational Medicine
  • Behavioural Problems In Alzheimers Disease
  • Biomarker Variables
  • Brain Disorders
  • Care And Quality Of Life
  • Care Practices In Dementia
  • Caregiver Support
  • Cognitive Training
  • Dementia
  • Dementia Care
  • Diagnosis And Symptoms
  • Education And Training Of Medical Professionals
  • EEG And Brain Mapping
  • Epilepsy
  • Frontotemporal Dementia
  • Functional Foods
  • Genetics In Dementia
  • Geriatrics And Cognitive Disorders
  • Imaging Animal Models
  • Imaging Correlates Of Clinical And Cognitive
  • Imaging Techniques
  • Managing Dementia
  • Mixed Dementia
  • Multi-infarct Dementia
  • Neuro Imaging
  • Neurodegenerative Diseases
  • Neurological Diseases
  • New Methods In Imaging
  • Non-pharmacological Interventions
  • Nursing And Care Practice
  • Parkinson Dementia
  • Parkinsons Disease
  • Pathophysiology Of Alzheimers Disease
  • Person Centered Care
  • Positron Emission Tomography
  • Post Stroke Dementia
  • Putting Scientific Knowledge Into Practice
  • Sleep And Dementia
  • SPECT Imaging
  • Stroke-related Dementia
  • Structural And Functional MRI
  • Traumatic Brain Injury
  • Treatment Of Alzheimers Disease
  • Vascular Dementia
  • White Matter And Dementia